PRAX
Income statement / Annual
Last year (2023), Praxis Precision Medicines, Inc.'s total revenue was $2.45 M,
and the percentage change from the previous year is not available.
In 2023, Praxis Precision Medicines, Inc.'s net income was -$123.28 M.
See Praxis Precision Medicines, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$2.45 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$86.77 M |
$1.17 M |
$1.59 M |
$746,000.00 |
$679,000.00 |
$1,000.00 |
| Gross Profit |
-$84.32 M |
-$1.17 M |
-$1.59 M |
-$746,000.00 |
-$679,000.00 |
-$1,000.00 |
| Gross Profit Ratio |
-34.46 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$86.77 M
|
$155.04 M
|
$120.26 M
|
$44.98 M
|
$29.56 M
|
$18.82 M
|
| General & Administrative
Expenses |
$42.05 M
|
$59.95 M
|
$47.08 M
|
$16.99 M
|
$6.23 M
|
$3.90 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$42.05 M
|
$59.95 M
|
$47.08 M
|
$16.99 M
|
$6.23 M
|
$3.90 M
|
| Other Expenses |
$0.00 |
$957,000.00 |
$271,000.00 |
$140,000.00 |
$0.00 |
-$3.65 M |
| Operating Expenses |
$128.82 M |
$214.99 M |
$167.33 M |
$61.97 M |
$35.79 M |
$22.72 M |
| Cost And Expenses |
$128.82 M |
$214.99 M |
$167.33 M |
$61.97 M |
$35.79 M |
$22.72 M |
| Interest Income |
$3.10 M |
$0.00 |
$271,000.00 |
$140,000.00 |
$193,000.00 |
$92,000.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$127,000.00 |
| Depreciation &
Amortization |
$432,000.00
|
$1.17 M
|
$1.59 M
|
$746,000.00
|
$679,000.00
|
$1,000.00
|
| EBITDA |
-$125.94 M
|
-$212.86 M
|
-$165.47 M
|
-$61.08 M
|
-$34.92 M
|
-$26.27 M
|
| EBITDA Ratio |
-51.47 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-51.64
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.10 M
|
$957,000.00
|
$271,000.00
|
$140,000.00
|
$193,000.00
|
-$3.68 M
|
| Income Before Tax |
-$123.28 M |
-$214.03 M |
-$167.06 M |
-$61.83 M |
-$35.60 M |
-$26.40 M |
| Income Before Tax Ratio
|
-50.38
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$957,000.00 |
-$182,000.00 |
-$8,000.00 |
-$84,000.00 |
$133,000.00 |
| Net Income |
-$123.28 M |
-$213.07 M |
-$166.88 M |
-$61.82 M |
-$35.51 M |
-$26.54 M |
| Net Income Ratio |
-50.38 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-18.69 |
-69.33 |
-58.96 |
-103.61 |
-348.24 |
-306.73 |
| EPS Diluted |
-18.69 |
-69.33 |
-58.96 |
-103.61 |
-348.24 |
-306.73 |
| Weighted Average Shares
Out |
$6.59 M
|
$3.07 M
|
$2.83 M
|
$596,677.00
|
$101,975.00
|
$86,509.00
|
| Weighted Average Shares
Out Diluted |
$6.59 M
|
$3.07 M
|
$2.83 M
|
$596,677.00
|
$101,975.00
|
$86,509.00
|
| Link |
|
|
|
|
|
|
